Job Description
Company Overview: Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases. Our mission to deliver innovative, life-saving medicines for serious unmet medical conditions drives us every day and contributes to building a sustainable business for the long term. It also inspires our entrepreneurial culture which fosters innovation, collaboration, and a relentless commitment to the people we serve. Patients are at the center of everything we do because everyday matters. Every employee is encouraged to take initiative, explore new ideas, and turn challenges into opportunities that can potentially transform lives, especially those suffering from serious and difficult-to-treat illnesses. Our products marketed in the U.S. include: GIAPREZA® (angiotensin II) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock. XACDURO® (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. XERAVA® (eravacycline) is a broad-spectrum antibiotic used to treat patients with complicated intra-abdominal infections (cIAI). ZEVTERA ® (ceftobiprole) is an approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis. In addition, Zevtera is approved in adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP). Nuzolvence® (zoliflodacin) for oral suspension is a first-in-class, single-dose oral antibiotic for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents 12 years of age and older weighing at least 35 kg. Summary of Position : This is a field-based position, assigned to the East Region (Albany, Binghamton, Watertown) The Critical Care Sales Specialist (CCSS) will partner with the Key Account Directors, National Account Directors, and field Medical Science Liaison Team to improve treatment in our targeted disease states and establish process in customer accounts to improve outcomes. Responsibilities will include developing tactical plans to establish consistent and sustainable sales growth within the territory, building relationships within the critical care and infectious disease communities to facilitate clinical discussion of where our products fit to improve outcomes. Responsibilities will include building strategic relationships within the critical care and infectious disease communities and be prepared to discuss clinical information. The CCSS will also understand the formulary process, P&T committee process, and decision-making processes germane to the addition of new therapies at each institution. The Critical Care Sales Specialist will be expected to have a high level of product knowledge, relevant institutional and HCP office relationships, and the ability to leverage all available avenues to influence their accounts. This includes the use of technology like Microsoft Teams, but most importantly the mindset of being present, live, in accounts. They will be able to demonstrate business acumen, the ability to formulate and execute a territory-specific strategy, the ability to communicate clinical data with impact and will be held accountable to consistent growth of all promoted products over time. Responsibilities : Work cross functionally to identify customer needs. Collaborate and communicate effectively with RBD (Regional Business Director), KAD (Key Account Director), NAD (National Account Director) and medical field partners (MSL Field Team) and others within the geographic region to deliver coordinated, efficient, effective, and appropriate approved product and disease state information. Consult with both state and local professional organizations and identify exhibit or engagement opportunities. Develop and maintain strong and long-term relationships with all key HCP’s that align to the product marketing strategy and other health care providers (collectively “HCP”) that see appropriate patients within the institutions or geographic area served. CCSS wi